Latest
industry research report on: Critical Care Therapeutics Market :
Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand,
Growth, Segmentation, Parameters, Forecasts
GBI Research, the leading business intelligence provider, has released its latest research: “Critical Care Therapeutics
in Major Developed Markets to 2020 - New and Late-Stage Four-Factor
PCCs and Recombinant Products to Drive Market”, which provides in-depth
analysis of the critical care market in the US, UK, France, Germany,
Italy, Spain, Japan and Canada. The report provides an estimation of
market size for 2013, along with market forecasts to 2020. It covers
critical care indications that are being treated using the five major
plasma-derived products of albumin, anti-thrombin concentrates, factor
XIII concentrates, fibrinogen concentrates, and prothrombin complex
concentrates.
The
total value of the critical care market in the major developed markets
was estimated at $1.8 billion in 2013 and is expected to grow at a
Compound Annual Growth Rate (CAGR) of 4.7% to $2.5 billion in 2019. This
growth is attributed to the recent approval of new factor concentrates
in the US that are expected to witness increasing uptake in the forecast
period. Factor concentrates are increasingly preferred due to their
lower infection risks over older alternatives such as FFP and
cryoprecipitate in critical care settings. The US accounts for the
largest share (41%) of the global critical care market and is expected
to post high growth at a CAGR of 7.5% until 2020.
KCentra,
the first four-factor PCC in the US, and Tretten, the first recombinant
FXIII concentrate, were approved in 2013 and are expected to witness
good uptake in the forecast period. Two additional factor concentrates
approved in the US in 2009 – RiaStap (human fibrinogen concentrate) and
ATryn (recombinant AT concentrate) – are also expected to increase their
uptake, which will contribute to market growth. With no new significant
launches in the forecast period, the European market is estimated to
witness much slower growth, with the UK at a CAGR of 3.0%, France at
2.5%, Germany and Spain both at 2.3%, and Italy at 2.0%
Download Sample copy of this Report at :http://www.marketresearchreports.biz/sample/sample/211679
Scope
The
report analyzes treatment usage patterns, market characterization,
pipeline analysis and key licensing and co-development deals in critical
care in the eight major developed markets of the US, UK, France,
Germany, Italy, Spain, Japan and Canada.
The report includes:
- A brief introduction to the five major plasma-derived products in critical care and the indications that they are being used to treat, as well as disease overview, epidemiology, other treatment options, and treatment patterns
- Analysis of major marketed products in critical care, covering product performance in terms of the safety and efficacy of recent approvals
- A review of the critical care pipeline, including individual analysis of promising late-stage pipeline drugs that are most likely to enter the market during the forecast period
- Multi-scenario forecasts of the critical care market over the 2013–2020 period in the eight major developed markets
- Key drivers and restraints that have had and are expected to have a significant impact on the market
- An overview of major licensing and co-development agreements that could affect growth trends
Reasons to Buy
- The report will enhance your decision-making capability by allowing you to:
- Align your product portfolio to markets with high growth potential
- Develop market entry and expansion strategies by identifying the regions and therapeutic segments poised for strong growth
- Devise effective, tailored strategies for each country through the understanding of key drivers and barriers in the critical care drugs market
- Develop key strategic initiatives based on an understanding of key focus areas and leading companies
- Accelerate and strengthen your market position by identifying key companies for mergers, acquisitions and strategic partnerships
About us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save time
and money for our clients. We are a one stop solution for all your
research needs, our main offerings are syndicated research reports,
custom research, subscription access and consulting services. We serve
all sizes and types of companies spanning across various industries.
Contact
Mr. Nachiket
State Tower
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-621-2074
No comments:
Post a Comment